Market Developments

The market for thrombosis care and diagnostics is developing rapidly. This requires a different vision, method of working and therefore a strategic repositioning for all involved.

For thrombosis care, the playing field is changing. Doing nothing is not an option; setting a clear course has become necessary for the continued existence of thrombosis services while maintaining the current business model. The rates are under pressure and new medication often means fewer clients. The counseling of clients with new medication also requires different services. Health insurers are positive about our Shared Service Center concept because anticoagulation expertise is secured, quality is maintained and even increased and because of the lower costs. Strategic repositioning is part of our service provision, whereby the changes become opportunities while retaining our identity.

The general practitioner and the client will have a greater role when it comes to diagnosis, guidance and monitoring of disease states. Trends that support this are studies that show GPs have a greater need for POCT in primary care. Health insurers are positive about more direction in primary care and with clients. eHealth is being stimulated in various ways, such as the SET subsidy and revision of traditional reimbursement structures. Digital consultations, remote care, pharmaceutical telecare and teledermatology are some examples.